Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Scientists at Joslin Diabetes Center have identified biological mechanisms by which glucagon-like peptide-1 (GLP-1), a gut hormone, protects against kidney disease, and also mechanisms that inhibit its actions in diabetes. The findings, which are reported today online by Diabetes, may lead to the development of new therapeutic agents that harness the actions of GLP-1 to prevent the harmful effects of hyperglycemia on renal endothelial cells.
http://www.sciencedaily.com/releases/2012/07/120723105045.htm
http://www.sciencedaily.com/releases/2012/07/120723105045.htm